GRAIL, Inc. $GRAL Shares Acquired by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. grew its holdings in GRAIL, Inc. (NASDAQ:GRAL) by 154,361.0% during the 4th quarter, Holdings Channel reports. The firm owned 91,132 shares of the company’s stock after buying an additional 91,073 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in GRAIL were worth $7,531,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of GRAL. Farallon Capital Management LLC grew its position in shares of GRAIL by 168.7% in the third quarter. Farallon Capital Management LLC now owns 1,349,000 shares of the company’s stock valued at $79,766,000 after purchasing an additional 847,000 shares during the last quarter. Bank of America Corp DE lifted its stake in shares of GRAIL by 121.0% during the third quarter. Bank of America Corp DE now owns 335,365 shares of the company’s stock valued at $19,830,000 after buying an additional 183,611 shares during the period. Allianz Asset Management GmbH lifted its stake in shares of GRAIL by 145.9% during the third quarter. Allianz Asset Management GmbH now owns 294,835 shares of the company’s stock valued at $17,434,000 after buying an additional 174,959 shares during the period. Vanguard Group Inc. lifted its stake in shares of GRAIL by 9.0% during the fourth quarter. Vanguard Group Inc. now owns 1,980,783 shares of the company’s stock valued at $169,535,000 after buying an additional 163,790 shares during the period. Finally, Invesco Ltd. lifted its stake in shares of GRAIL by 259.1% during the second quarter. Invesco Ltd. now owns 218,671 shares of the company’s stock valued at $11,244,000 after buying an additional 157,780 shares during the period.

GRAIL Stock Performance

Shares of GRAL opened at $67.19 on Friday. The company has a market capitalization of $2.88 billion, a price-to-earnings ratio of -6.48 and a beta of 3.03. GRAIL, Inc. has a 1 year low of $29.95 and a 1 year high of $118.84. The company’s 50 day simple moving average is $53.45 and its 200 day simple moving average is $76.65.

GRAIL (NASDAQ:GRAL) last posted its quarterly earnings results on Tuesday, May 5th. The company reported ($2.29) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.76) by $0.47. The company had revenue of $40.79 million for the quarter, compared to the consensus estimate of $39.16 million. GRAIL had a negative net margin of 253.22% and a negative return on equity of 16.42%. Equities analysts expect that GRAIL, Inc. will post -10.91 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on GRAL shares. Morgan Stanley reduced their price objective on shares of GRAIL from $110.00 to $60.00 and set an “equal weight” rating on the stock in a research note on Tuesday, February 24th. Wall Street Zen raised shares of GRAIL from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Piper Sandler upped their price objective on shares of GRAIL from $54.00 to $56.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Mizuho started coverage on shares of GRAIL in a research note on Friday, April 10th. They set a “neutral” rating and a $58.00 price objective on the stock. Finally, TD Cowen upped their price objective on shares of GRAIL from $65.00 to $69.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Four investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, GRAIL presently has an average rating of “Hold” and a consensus price target of $67.88.

Insiders Place Their Bets

In other GRAIL news, President Joshua J. Ofman sold 61,665 shares of the stock in a transaction that occurred on Wednesday, April 8th. The shares were sold at an average price of $49.92, for a total transaction of $3,078,316.80. Following the transaction, the president owned 371,216 shares of the company’s stock, valued at $18,531,102.72. This trade represents a 14.25% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Robert P. Ragusa sold 123,502 shares of the stock in a transaction that occurred on Wednesday, April 8th. The stock was sold at an average price of $49.92, for a total transaction of $6,165,219.84. Following the transaction, the chief executive officer directly owned 518,582 shares in the company, valued at approximately $25,887,613.44. This represents a 19.23% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 310,267 shares of company stock valued at $15,485,396 over the last quarter. Company insiders own 1.83% of the company’s stock.

GRAIL Company Profile

GRAIL, Inc (NASDAQ: GRAL) is a biotechnology company dedicated to the early detection of cancer through a multi-cancer blood test. Leveraging advances in next-generation sequencing, cell-free DNA (cfDNA) analysis and machine learning, GRAIL has developed the Galleri™ test, which aims to identify more than 50 types of cancer at their earliest stages. The company’s platform analyzes methylation patterns in circulating tumor DNA to pinpoint tumor presence and tissue of origin, enabling physicians to pursue timely diagnostic follow-up.

Founded in 2016 as a spin-out from Illumina, GRAIL established its headquarters in Menlo Park, California, with additional research and operations centers in the United Kingdom.